ISSN: 0975-0851
Journal of Bioequivalence & Bioavailability
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Recommended Conferences
- European Biopharma Congress
November 16-17, 2017 Vienna, Austria - 11th International Conference on Immunopharmacology and Immunotoxicology
Nov 20-21, 2017 Melbourne, Australia - 17th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care
Nov 23-24, 2017 Melbourne, Australia - 20th International Conference on Pharmaceutical Biotechnology
December 07-09, 2017 Madrid, Spain
Recommended Journals
Relevant Topics
- Advances in Bioavailability
- Advances in pharmaceutical analytical methods
- Air analysis
- Anthropology Biomedicine
- Antigen â Antibody Reaction
- Anvisa Bioequivalence
- Anvisa regulatory guidelines
- Applied Biomedicine
- BA/BE Studies
- Bioanalysis Methods
- Bioanalytical Chemistry
- Bioanalytical Method Validation
- Bioequivalence Anticancers
- Bioequivalence Antidiabetics
- Bioequivalence Antidiuretics
- Bioequivalence Antipsychotics
- Bioequivalence Cardiovascular Products
- Bioequivalence Study Design
- Bioequivalence Study Protocols
- Biomedicine and Pharmacotherapy
- Biopharmaceutics
- Biosimilars
- British regulatory guidelines
- Cell genetics
- Chemical analysis
- Chromatographic Techniques
- Clinical Cancer Trials
- Clinical Drug Trial
- Competitive analysis of drugs
- Computational Biomedicine
- Drug Delivery using Nanotechnology
- Drug Designing
- Drug analysis
- Drug devices
- European Bioequivalence
- Europian regulatory guidelines
- Experimental Drug Trial
- FDA Bioequivalence
- Fragment Based Drug Design
- Heat Shock Proteins
- In Silico Methods
- In vitro Bioequivalence
- Japan regulatory guidelines
- Marine Biomedicine
- Mass Spectroscopy
- Medical Biology
- Medical devices regulations
- Molecular Biomedicine
- Molecular Epidemiology
- Molecular Modeling
- NMR Applications in Biomedicine
- Nanomedicals
- Negative Results in Biomedicine
- Paid Clinical Trials
- Peptidomimetic
- Pharmaceutical analysis
- Pharmaceutical analytical market
- Pharmaceutical care
- Pharmaceutical companies and regulatory guidelines
- Pharmaceutical ethics
- Pharmaceutical formulation
- Pharmaceutical technology
- Pharmaceutics
- Product analysis and marketing
- Protease Substrate/Inhibitor
- Quality assurance in pharmaceutical analysis
- Quality assurance in regulatory affairs
- Receptor Agonist/ Antagonist
- Regulatory Requirements in Bioequivalence
- Regulatory affairs
- Regulatory affairs for clinical trails
- Regulatory compliance
- Regulatory consulting and market analysis
- Regulatory requirements of pharmaceutical products
- Regulatory services and market analysis
- Spectrometry
- Sports Biomedicine
- Structure Based Drug Design
- Systems Biomedicine
- US FDA guidelines
- Validation
- screening and Drug Design
Kun Fang Ma |
||
| School of Pharmacy at Nanjing Medical University, China. | ||
| Biography | ||
Dr.Kun Fang Ma GR is currently working in School of Pharmacy at Nanjing Medical University, China. |
||
| Research Interest | ||
Pharmacokinetics, Bioequivalence & Bioavailability. |
||
| Publications | ||
|
Mei Juan Ding, Li Hua Yuan, Yun Li, Shu Wang, Xiao Li Wu, Jie Liu, Kun Fang Ma, Hong Wei Fan, Zhen Yu Lu, Hui Juan Xu and Xue Min Zhou Research Article: JBB/Vol.3.2 032-037 (2011) |
||
Global Speakers in the subjectGlobal Experts in the subject |
||
Relevant Conferences
- Drug Metabolism
Euro Biopharma 2017 (Austria) - Bioavailability/Bioequivalence on Biopharmaceutical Products
Euro Biopharma 2017 (Austria) - Biologics and Biosimilars
Euro Biopharma 2017 (Austria) - Biopharmaceutical Companies & Market Analysis
Euro Biopharma 2017 (Austria) - Biopharmaceutical Pharmacovigilance
Euro Biopharma 2017 (Austria) - Biopharmaceutics: Drug Discovery and Development
Euro Biopharma 2017 (Austria) - Biotechnological Products
Euro Biopharma 2017 (Austria) - Cellular and Gene Therapy
Euro Biopharma 2017 (Austria) - Clinical Trials on Biopharmaceutical Products
Euro Biopharma 2017 (Austria) - Drug Delivery System of Biopharmaceutical Products
Euro Biopharma 2017 (Austria) - Drug Disposition & Pharmacokinetics
Euro Biopharma 2017 (Austria) - Drug Dissolution of Biopharmaceutical Products
Euro Biopharma 2017 (Austria) - Entrepreneurs Investment Meet
Euro Biopharma 2017 (Austria) - Gene Therapy
Euro Biopharma 2017 (Austria) - Oral Drug Absorption
Euro Biopharma 2017 (Austria) - Pharmaceutical Regulatory Affairs And IPR
Euro Biopharma 2017 (Austria) - Pharmacodynamics
Euro Biopharma 2017 (Austria) - Therapeutic Biological Products
Euro Biopharma 2017 (Austria) - Allergy
Immunopharmacology 2017 (Australia) - Antibody arrays
Immunopharmacology 2017 (Australia) - Autoimmune Disorders
Immunopharmacology 2017 (Australia) - Clinical Applications of Immunopharmacology
Immunopharmacology 2017 (Australia) - Immuno bacteriology
Immunopharmacology 2017 (Australia) - Immuno Virology
Immunopharmacology 2017 (Australia) - Immunoenancers
Immunopharmacology 2017 (Australia) - Immunologists
Immunopharmacology 2017 (Australia) - Immunomodulators
Immunopharmacology 2017 (Australia) - Immunopathology
Immunopharmacology 2017 (Australia) - Immunopharmacology
Immunopharmacology 2017 (Australia) - Immunosuppressants
Immunopharmacology 2017 (Australia) - Immunotherapy
Immunopharmacology 2017 (Australia) - Immunotoxicology
Immunopharmacology 2017 (Australia) - Latest research reviews and discoveries in immunology
Immunopharmacology 2017 (Australia) - Neuroimmunology
Immunopharmacology 2017 (Australia) - Neuroimmunomodulation
Immunopharmacology 2017 (Australia) - Paediatric Immunology
Immunopharmacology 2017 (Australia) - Pharmacology
Immunopharmacology 2017 (Australia) - Stems Cells and Immunity
Immunopharmacology 2017 (Australia) - Veterinary Immunology
Immunopharmacology 2017 (Australia) - Advanced Characterization of Nanomaterials
Nanomedicine 2017 (Australia) - Applications of Nanotechnology in Health Care
Nanomedicine 2017 (Australia) - Biomaterials and Medical Devices
Nanomedicine 2017 (Australia) - Entrepreneur Investment Meet
Nanomedicine 2017 (Australia) - Future prospects of Nanotechnologies and commercial viability
Nanomedicine 2017 (Australia) - Graphene modification and functionalization
Nanomedicine 2017 (Australia) - Nano Composites and Multiscale Nano materials
Nanomedicine 2017 (Australia) - Nano in Pharmaceutical Chemistry
Nanomedicine 2017 (Australia) - Nano medicine and Nano pharmaceuticals
Nanomedicine 2017 (Australia) - Nanoethics and Regulations
Nanomedicine 2017 (Australia) - Nanomaterials and Nanotechnology
Nanomedicine 2017 (Australia) - Nanomedicine
Nanomedicine 2017 (Australia) - Nanomedicine and Cancer
Nanomedicine 2017 (Australia) - Nanomedicine and Drug delivery
Nanomedicine 2017 (Australia) - Nanomedicine and Healthcare
Nanomedicine 2017 (Australia) - Nanomedicine and Nanobiotechnology
Nanomedicine 2017 (Australia) - Nanomedicine and Nanobiotechnology
Nanomedicine 2017 (Australia) - Nanomedicine and Nanodiagnostics
Nanomedicine 2017 (Australia) - Nanomedicine and Nanomedical Devices
Nanomedicine 2017 (Australia) - Nanomedicine and Nanopharmaceuticals
Nanomedicine 2017 (Australia) - Nanomedicine and Nanotheranostics
Nanomedicine 2017 (Australia) - Nanomedicine and Nanotoxicology
Nanomedicine 2017 (Australia) - Nanomedicine and Tissue Engineering
Nanomedicine 2017 (Australia) - Nanomedicine in Drug Delivery Systems
Nanomedicine 2017 (Australia) - Nanomedicine Technologies
Nanomedicine 2017 (Australia) - Nanotechnology for Environment and Nano safety
Nanomedicine 2017 (Australia) - Nanotechnology for Environment and Nano safety
Nanomedicine 2017 (Australia) - Nanotechnology in Healthcare
Nanomedicine 2017 (Australia) - Advances in Biotech Manufacturing
Pharma Biotech 2017 (Spain) - Agriculture Biotechnology
Pharma Biotech 2017 (Spain) - Biomass and Bioenergy
Pharma Biotech 2017 (Spain) - Biopharmaceutical Engineering
Pharma Biotech 2017 (Spain) - Biopharmaceutical Production in Transgenic Animals
Pharma Biotech 2017 (Spain) - Biopharmaceuticals
Pharma Biotech 2017 (Spain) - Biotech Companies and Market Analysis
Pharma Biotech 2017 (Spain) - Biotechnology and its Applications
Pharma Biotech 2017 (Spain) - Biotechnology in Health Care
Pharma Biotech 2017 (Spain) - Chemical Biotechnology
Pharma Biotech 2017 (Spain) - Development on Recombinant Protein
Pharma Biotech 2017 (Spain) - Formulation of Biotech Products
Pharma Biotech 2017 (Spain) - Industrial and Microbial Biotechnology
Pharma Biotech 2017 (Spain) - Nanobiotechnology
Pharma Biotech 2017 (Spain) - Nanoparticles in Biopharmaceuticals
Pharma Biotech 2017 (Spain) - Novel Approaches in Biopharmaceutics
Pharma Biotech 2017 (Spain)
